Epstein Secrets

becomes symtomatic. =br> Anthony Barrett Begin forwar=ed message: From: Franci= Barany Date: October 8, 2014 . . To: An=hony Barrett < =b>Cc: Michael Gargano > Subject: Confidential: Ea=ly detection of Ebola Dear Anthony, I really appreciate your willingness to find a potential pathway to Bil= Gates an

evices suitable f=r working in developing countries, and may be powered and run by a cell phone or smart device. • Current CDC approved EZ1-RT-P=R Taqman assay has LOD of 5,000 PFU/ml. This works when patient is&nbs=;febrile, i.e. has overt symptoms and may be contagious. • Next level of assay needs

mtomatic. Ant=ony Barrett Begin forwarded message: <=div> From: Francis Barany Date: October 8, 2014 at 6:06:32 PM EDT To: An=hony Barrett Cc: Michael Gargano >=br>Subject: Confidential: Early detection of Ebola </=iv> Dear Anthony, I really appreciate your willingness to find a potential pathway to Bi

ricated devices that w=ll allow for electronic detection, obviating the need for expens=ve hardware used in most fluorescent detection schemes (i.e. Taqman a=says). As such, we are poised to combine these technologie= for rapidly identifying and providing quantitative viral load fo= all the VHF, Variol

s symtomatic. Anthony Barrett Begin forwa=ded message: From: Franc=s Barany < Date: October 8, 2014 at 6:06:32 PM E=T To: Anthony Barrett < Cc: Michael Gargano animagonflialmina Subject: Confidential: Early detection of Ebola<=b> Dear Anthony, I really appreciate your willingness to find a potential pathw

devices suitable f=r working in developing countries, and may be powered and run by a cell phone or smart device. • Current CDC approved EZ1-RT-P=R Taqman assay has LOD of 5,000 PFU/ml. This works when patient is&nbs=;febrile, i.e. has overt symptoms and may be contagious. • Next level of assay needs